GL1X · GenesisL1 explorer

MolNFT v1 · #107431 · protein

Ctx-M-14 class a beta-lactamase in complex with a non-covalent inhibitor at sub-ångström resolution

4UA7 · Beta-lactamase ctx-M-14: “Ctx-M-14 class a beta-lactamase in complex with a non-covalent inhibitor at sub-ångström resolution”. X-ray diffraction, 2 ligands (3GK, PO4), 2 pockets (best druggability 0.36). MolNFT v1 #107431 on…

PDB
4UA7
Type
protein
Length
523 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Beta-lactamase ctx-M-14
UniProt
H6UQI0
Ligands
3GK, PO4
Pockets
2 · best druggability 0.36

Structure

x-ray diffraction · 2 distinct chains · 44% helix, 19% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
ABeta-lactamase ctx-M-14protein26344% helix, 19% strandH6UQI0
BBeta-lactamase ctx-M-14protein26043% helix, 19% strandH6UQI0

Ligands and binding sites

  • 3GK · N-[3-(2H-tetrazol-5-yl)phenyl]-6-(trifluoromethyl)-1H-benzimidazole-4-carboxamide · ligand · 4 copies · chains A, B
  • PO4 · Phosphate ion · ion · 3 copies · chains A, B

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11000.360.75213GK
2660.300.75193GK

Interfaces

1 interface between chains.

  • A–B · 120 Ų buried · 1 hydrogen bond · protein-protein

Modifications

Observed in the structure: 1 modified (cyclization).

Compared structures

  • 4UA7 · CTX-M-14 Class A Beta-Lactamase in Complex with a Non-Covalent Inhibitor at Sub-Angstrom… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.